• Advanced Base: FoamaDerm™ is designed for enhanced drug delivery through the skin. Our studies showed better diclofenac release from FoamaDerm™ compared to other bases and the brand product; therefore it can be more effective at lower concentration (up to 3%) as compared to 5% or 10% in other bases.

  • Patient tested: Effectiveness of FoamaDerm™ has been tested at the University of Alberta on patients suffering from chronic pain. Click to read the article

  • Better safety profile: up to 3% diclofenac in FoamaDerm base has better drug release compared to other bases. 

  • Better spreadibility and easy to clean foam

  • Foam leaves no greasy residue on skin allowing convenient any time application

  • Easy to apply with gentle rubbing, for convenient application on areas that are hurting

Recommended dose:

FoamaDerm™ is formulated for up to 3% diclofenac sodium. Diclofenac has superior drug release profile from FoamaDerm™ compared to other bases and shows better effect, therefore there is no need to prescribe higher doses such as 5% or 10% of diclofenac.

The following ingredients can also be added to FoamaDerm™:

Ketoprofen up to 3%

Lidocaine up to 3%

Menthol and camphor up to 1%

Ketamine up to 4%

Adding other ingredients or other concentrations has not been studied.

Greater patient convenience

Please visit our FAQs section for answer to some of the common questions.

Terms and Conditions 

All right reserved.

Copyright  2020 RS Therapeutics Inc. 

  • Twitter
  • YouTube
  • Facebook